Attention-deficit hyperactivity disorder, drug companies and the internet

Mitchell, Jessica; Read, John

doi:10.1177/1359104510396432

Cited by 23 publications

(41 citation statements)

References 74 publications

(95 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All of the Web sites were easy to navigate and understand for a first time user. This finding was largely inconsistent with the Web site research undertaken by Mitchell and Read (2012), who found that information on many Web sites was written in highly technical language. Fewer than 33% of the Web sites evaluated disclosed authorship of the information displayed, and fewer than half of those displayed both authorship and the author's actual qualifications.…”

contrasting

confidence: 69%

See 1 more Smart Citation

An Evaluation of the Quality and Content of Web Sites on Cancer Related Fatigue

D'Silva

Kessel

2014

Journal of Consumer Health On the Internet

View full text Add to dashboard Cite

Cancer-related fatigue is a common symptom for cancer patients. Due to a lack of information from health professionals about cancer-related fatigue, patients often seek information from the Internet. This study evaluated the quality and accuracy of cancer-related fatigue content available online and determined whether any relationships existed between indicators of quality of Web site and accuracy of content. A sample of 25 cancer-related fatigue Web sites was evaluated for quality and accuracy of content using a total score against a checklist of adopted criteria. Although no correlation was found between the quality of Web sites and the accuracy of content, Web sites with accurate information about the causes of cancer-related fatigue were associated with significantly higher total scores. Similarly, Web sites with accurate information pertaining to psychosocial factors were also associated with a significantly higher total score. This suggests that accurate content is significantly related to the overall performance of a Web site. Likewise, significantly higher total scores were obtained for Web sites that included accurate etiological information on the potential interactions of biological processes, psychosocial factors, and other factors such as demographics. A list of the top performing cancer-related fatigue Web sites based on quality and accuracy of content criteria is presented.

show abstract

contrasting

confidence: 69%

“…Web sites devoted to modern health issues have become the public's main source of information (Mitchell and Read 2012). Anderson and Klemm (2008) suggest that the Internet has changed how patients with chronic illness, especially cancer patients, learn about their disease and how to cope with it.…”

Section: Internet-based Healthmentioning

confidence: 99%

An Evaluation of the Quality and Content of Web Sites on Cancer Related Fatigue

D'Silva

Kessel

2014

Journal of Consumer Health On the Internet

View full text Add to dashboard Cite

show abstract

“…(Erlandsson et al, 2016; (Freedman, 2015; Mitchell & Read, 2012). This may have contributed to the rising use of medication over the years.…”

Section: Medication Does Not Benefit Most Children In the Long Runmentioning

confidence: 99%

ADHD: a critical update for educational professionals

Meerman

Batstra

Grietens

et al. 2017

International Journal of Qualitative Studies on Health and Well

View full text Add to dashboard Cite

A medical approach towards behavioural problems could make professionals without a medical background, like teachers and other educational professionals feel inapt. In this article, we raise six scientifically grounded considerations regarding ADHD, currently the most prevalent childhood psychiatric diagnosis. These “need to knows” show just how misguided and potentially stigmatizing current conceptualizations of unruly behaviour have become. Some examples are given of how teachers are misinformed, and alternative ways of reporting about neuropsychological research are suggested. A reinvigorated conceptual understanding of ADHD could help educational institutions to avoid the expensive outsourcing of behavioural problems that could also—and justifiably better—be framed as part of education’s primary mission of professionalized socialization.

show abstract

“…In this review, we focus on the sympathomimetic actions of MPH currently the most widely used ADHD drug [102,103] within a quite dynamic market [103]-on cardiovascular function, which represent an issue of concern [104]. However, because the sympathomimetic action of MPH is similar to that of both amphetamine salts and atomoxetine, the same concerns pertaining to long-term cardiovascular safety also apply to these medications.…”

Section: Pharmacological Data and Potential Consequencesmentioning

confidence: 98%

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Antel

Albayrak

Heusch³

et al. 2014

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

With the recent approval of methylphenidate (MPH) for treating attention-deficit/hyperactivity disorder (ADHD) in adults, the number of patients exposed will increase tremendously. The ongoing debate on the cardiovascular safety of MPH has triggered two large retrospective cohort studies in children and adolescents as well as in young to middle-aged adults. These studies looked into serious cardiovascular events (sudden cardiac death, acute myocardial infarction and stroke) as primary endpoints and concluded that MPH was safe after a mean duration of 2.1 years of follow-up in children and adolescents and mean duration of 0.33 years of current use in adults. The results are encouraging with respect to the short- and medium-term use of MPH. Without the inherent limitations of retrospective cohort studies, a prospective randomized, double-blind, placebo-controlled, multicenter trial in individuals stratified for cardiovascular risk factors would allow for an optimized risk assessment. With many millions of patients treated per year and drawing parallels to the lately discovered risks of sibutramine, another sympathomimetic with an overlapping mode of action and similar side effects on heart rate and blood pressure, we hypothesize that such a trial might be a dedicated risk mitigation strategy for public health. A critical assessment of cardiovascular side effects of MPH appears particularly warranted, because ADHD is associated with obesity, smoking and poor health in general. We summarize recent findings with the focus on cardiovascular risks of MPH in humans; we additionally analyze the limited number of rodent studies that have addressed cardiovascular risks of MPH.

show abstract

Attention-deficit hyperactivity disorder, drug companies and the internet

Cited by 23 publications

References 74 publications

An Evaluation of the Quality and Content of Web Sites on Cancer Related Fatigue

An Evaluation of the Quality and Content of Web Sites on Cancer Related Fatigue

ADHD: a critical update for educational professionals

Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Contact Info

Product

Resources

About